First Citizens, Huntington, BankUnited provide $173 million term loan facility for Pivot Energy solar portfolio
Bitget2026/10/08 12:04Pivot Energy closed a USD 173 million term loan facility for a 135 MWdc distributed solar portfolio spanning 51 community-scale projects. First Citizens BancShares participated in the takeout financing alongside Huntington Bank and BankUnited. Proceeds refinanced projects from Pivot’s construction warehouse, consolidating three portfolios into a single term structure. The deal increased capacity under Pivot’s revolving construction facility to support additional project builds. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. First Citizens BancShares Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: NY66629) on October 08, 2026, and is solely responsible for the information contained therein.
- Pivot Energy closed a USD 173 million term loan facility for a 135 MWdc distributed solar portfolio spanning 51 community-scale projects.
- First Citizens BancShares participated in the takeout financing alongside Huntington Bank and BankUnited.
- Proceeds refinanced projects from Pivot’s construction warehouse, consolidating three portfolios into a single term structure.
- The deal increased capacity under Pivot’s revolving construction facility to support additional project builds.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Canaccord Genuity: Lowers Oklo's target price to $66
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss
Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.
Crypto prices
More
